Thomas Mühlenberg

7PUBLICATIONS
41CO-AUTHORS
Molecular targetsHistorical, comparative and typological linguisticsPharmacogenomicsMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Jul 08, 2024
Reply to Y. Xia et al.

Sebastian Bauer, Jonathan A Fletcher, Daniel Rauh

|Feb 26, 2024
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.

Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz

|Jan 03, 2024
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA.

A Teuber, T Schulz, B S Fletcher

|Nov 26, 2022
Plasma Sequencing for Patients with GIST-Limitations and Opportunities in an Academic Setting.

Johanna Falkenhorst, Susanne Grunewald, Dawid Krzeciesa

|Sep 25, 2020
Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain.

Susanne Grunewald, Lillian R Klug, Thomas Mühlenberg

Pageof 2

Frequent Collaborators

6 joint publications

Sebastian Bauer

5 joint publications

Daniel Rauh

4 joint publications

Johanna Falkenhorst

3 joint publications

Tom Schulz